Physician profile
Connor A King
NPI 1750761003
$4,828.62
in general payments reported to CMS, 2019-2025
15 companies · $515 in 2025
The $515 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $631 · 2020: $350 · 2021: $1,775 · 2022: $506 · 2023: $311 · 2024: $742 · 2025: $515.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,568.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,567.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,956.83 | 2019-2025 | Mako |
| Medical Device Business Services, INC. | $539.93 | 2019-2020 | |
| Depuy Synthes Sales INC. | $327.33 | 2021-2023 | |
| Smith+Nephew, INC. | $323.44 | 2022-2024 | Real Intelligence, Journey II |
| Innovation Technologies INC | $193.49 | 2021-2023 | Irrisept |
| Astrazeneca Pharmaceuticals LP | $117.92 | 2024 | Lynparza |
| Aesculap Implant Systems, LLC | $93.35 | 2023 | As Columbus Revision F |
| Convatec INC. | $56.23 | 2021 | |
| Ferring Pharmaceuticals INC. | $51.16 | 2022-2023 | Euflexxa |
| Zimmer Biomet Holdings, INC. | $48.00 | 2022 | |
| Nalu Medical, INC. | $47.38 | 2022-2023 | Nalu Neurostimulation System |
| Zimvie INC. | $25.11 | 2022 | |
| Medtronic, INC. | $20.00 | 2023 | Aquamantys(Tm) |
| Sanara Medtech INC. | $15.67 | 2023 | Celleraterx |
| Bioventus LLC | $12.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Connor King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.